Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)



*Denotes required.


Unveiling CQA Insights for mRNA, LNPs, and Viral Vectors by SEC and MALS With Novel 1000 Å Ultrawide Pore Particle Columns

This event is now available on demand!

Event Overview:

The recent pandemic has accelerated advancements in medicine, particularly with nucleic acid-based therapies such as mRNA, LNP delivery systems, and viral vectors. Ensuring the quality and integrity of these therapeutics is crucial, highlighting the importance of size exclusion chromatography (SEC) combined with MALS. This webinar will focus on using 1000 Å ultrawide pore columns with MALS to analyze long-chain nucleic acids, LNPs, and viral vector formulations, covering methods for mRNA integrity, LNP heterogeneity, and aggregate analysis.

Key Learning Objectives:
  • Create high-resolution, robust, multi-attribute techniques for analyzing mRNA integrity and aggregates
  • Establish method conditions for analyzing the heterogeneity of intact lipid nanoparticles (LNPs)
  • Conduct aggregate analysis and identify degradation pathways with high-efficiency, low-absorption hardware using the new 1000 Å ultrawide pore columns
Who Should Attend:
  • Academic researchers involved in biophysical studies
  • Academic researchers involved in gene therapy studies
  • Protein, lipid nanoparticle, and gene therapy: development scientists and lab managers
  • Protein, lipid nanoparticle, and gene therapy: QC scientists and lab managers
  • Lab managers, senior scientists
  • Government researchers involved in gene therapy and lipid nanoparticle research
Featured Speakers:

Adam Crowe, PhD
Adam Crowe, PhD
Senior manager, analytical development
Precision NanoSystems, part of Cytvia


Adam Crowe, PhD, received his doctorate in biochemistry from the University of British Columbia. After serving briefly as a postdoc, he joined Precision NanoSystems, a part of Cytiva. Dr Crowe manages a multidiscipline team that is tasked with developing novel analytical assays for lipid nanoparticles (LNP) and nanomaterials for drug delivery. Dr Crowe and his team have increasingly leveraged cutting-edge technologies, such as LC-MS approaches, to tackle the complexities of LNP characterization. Their latest studies were focused on the detail characterization of impurities found in ionizable liquids.



Lavelay Kizekai, BS
Lavelay Kizekai, BS
Principal Scientist
Waters Corporation


Lavelay Kizekai, BS, is a principal scientist at Waters Corporation. He joined Waters in 2009 and has since applied himself to developing new LC methods, leading column technology product development work, and establishing insight-based QC procedures for Waters products. His primary area of focus is biomolecule separations using size-exclusion chromatography (SEC). He was a core member of the team that recently brought to market a column suited to platform methods for monoclonal antibodies and antibody-drug conjugates. He is currently leveraging these SEC technologies and even newer breakthroughs for the characterization of gene-based therapeutics by multiangle light scattering SEC-MALS.

Speaker’s Email: Lavelay_kizekai@waters.com
Speaker’s LinkedIn: Lavelay Kizekai - Principal Scientist - Waters Corporation | LinkedIn


Mandana Fasth, MS
Mandana Fasth, MS
Global Principal Product and Marketing Manager
Waters Corporation


Mandana Fasth, MS, is the global principal product and marketing manager at Waters Corporation. She received her master’s degree in biochemistry from Uppsala University in Sweden. With more than 20 years of experience working with biologics workflows such as size-exclusion chromatography and column development projects, she is well versed in training and supporting scientists with method development for characterization and purification of biologics.

Speaker’s Email: mandana_fasth@waters.com
Speaker’s LinkedIn: Mandana Fasth - Waters Corporation | LinkedIn

For any technical questions please contact Kristina Dunphey: kdunphey@mjhevents.com